Monashee Investment Management »

Structure Therapeutics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.8M 192k 40.76
2023-09-30 $32M 634k 50.42
2023-06-30 $23M 1.4M 16.60
2023-03-31 $4.0M 170k 23.79

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding Structure Therapeutics

Wellington Management Company
venBio Select Advisor
Federated Investors
Avidity Partners Management
T. Rowe Price Associates
Henderson Group
Citadel Advisors
Casdin Capital
Logos Global Management
Sc China Holding
Deerfield Management Company
BVF
Caption Management
Franklin Resources
RA Capital Management

View all funds holding Structure Therapeutics